Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease
Authors:
- Anna Ludwicka-BradleyALAnna Ludwicka-Bradley
- Richard M. SilverRSRichard M. Silver
- Galina S. BogatkevichGBGalina S. Bogatkevich
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 41 (2) , 212-222
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K01AR051052)
This publication has 107 references indexed in Scilit:
- Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblastsArthritis & Rheumatism, 2009
- Natural killer cell cytotoxicity: how do they pull the trigger?Immunology, 2009
- Regulation of pulmonary inflammation and fibrosis through expression of integrins αVβ3 and αVβ5 on pulmonary T lymphocytesArthritis & Rheumatism, 2009
- Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- The cell‐based model of coagulationJournal of Veterinary Emergency and Critical Care, 2009
- Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic FibrosisDevelopmental Cell, 2009
- T cell polarization identifies distinct clinical phenotypes in scleroderma lung diseaseArthritis & Rheumatism, 2008
- Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?British Journal of Pharmacology, 2008
- Thrombin and TNF-α/IL-1β Synergistically Induce Fibroblast-Mediated Collagen Gel DegradationAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002